This suggests that restriction of ubiquitination activity may be critical to prevent breast cancer cell growth and metabolic reprogramming, as GPS2 deletion is associated with increased expression of the MYC gene and altered expression of genes involved in cancer progression, metastatic potential, mitochondrial functions, and lipid metabolism. The gene discussed is MYC; the disease is breast carcinoma.